ID int64 6 67 | author stringclasses 23
values | year int64 2.01k 2.02k | cancerType stringclasses 13
values | cellLine stringclasses 27
values | time int64 8 144 | coumarin stringclasses 2
values | coumarinDose float64 0.1 335 | viability float64 3.66 109 | viabilitySD float64 0.5 24.6 | viabilityN int64 2 6 | control float64 77.3 111 | controlSD float64 0.86 12.5 | controlN int64 2 6 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
43 | Goodarzi et al. | 2,022 | Leukemia/Lymphoma | MT-2 | 72 | Umbelliprenin | 20 | 99.09 | 1.51 | 3 | 99.39 | 1.51 | 3 |
43 | Goodarzi et al. | 2,022 | Leukemia/Lymphoma | MT-2 | 72 | Umbelliprenin | 40 | 95.79 | 4.27 | 3 | 99.39 | 1.51 | 3 |
43 | Goodarzi et al. | 2,022 | Leukemia/Lymphoma | MT-2 | 72 | Umbelliprenin | 80 | 60.06 | 12.61 | 3 | 99.39 | 1.51 | 3 |
43 | Goodarzi et al. | 2,022 | Leukemia/Lymphoma | MT-2 | 96 | Umbelliprenin | 1 | 87.08 | 14.42 | 3 | 98.79 | 2.41 | 3 |
43 | Goodarzi et al. | 2,022 | Leukemia/Lymphoma | MT-2 | 96 | Umbelliprenin | 40 | 75.67 | 24.63 | 3 | 98.79 | 2.41 | 3 |
43 | Goodarzi et al. | 2,022 | Leukemia/Lymphoma | MT-2 | 96 | Umbelliprenin | 80 | 60.06 | 4.8 | 3 | 98.79 | 2.41 | 3 |
54 | Hamidinia et al. | 2,013 | Colon | SW48 | 24 | Umbelliprenin | 6.25 | 95.66 | 1.45 | 3 | 100 | 2.29 | 3 |
54 | Hamidinia et al. | 2,013 | Colon | SW48 | 24 | Umbelliprenin | 12.5 | 93.85 | 1.09 | 3 | 100 | 2.29 | 3 |
54 | Hamidinia et al. | 2,013 | Colon | SW48 | 24 | Umbelliprenin | 25 | 85.51 | 1.08 | 3 | 100 | 2.29 | 3 |
54 | Hamidinia et al. | 2,013 | Colon | SW48 | 24 | Umbelliprenin | 50 | 76.82 | 5.8 | 3 | 100 | 2.29 | 3 |
54 | Hamidinia et al. | 2,013 | Colon | SW48 | 24 | Umbelliprenin | 100 | 56.89 | 2.17 | 3 | 100 | 2.29 | 3 |
54 | Hamidinia et al. | 2,013 | Colon | SW48 | 24 | Umbelliprenin | 200 | 23.56 | 1.82 | 3 | 100 | 2.29 | 3 |
54 | Hamidinia et al. | 2,013 | Colon | SW48 | 48 | Umbelliprenin | 6.25 | 95.29 | 2.53 | 3 | 100 | 2.29 | 3 |
54 | Hamidinia et al. | 2,013 | Colon | SW48 | 48 | Umbelliprenin | 12.5 | 92.76 | 1.45 | 3 | 100 | 2.29 | 3 |
54 | Hamidinia et al. | 2,013 | Colon | SW48 | 48 | Umbelliprenin | 25 | 81.53 | 2.54 | 3 | 100 | 2.29 | 3 |
54 | Hamidinia et al. | 2,013 | Colon | SW48 | 48 | Umbelliprenin | 50 | 70.29 | 2.53 | 3 | 100 | 2.29 | 3 |
54 | Hamidinia et al. | 2,013 | Colon | SW48 | 48 | Umbelliprenin | 100 | 33.34 | 1.09 | 3 | 100 | 2.29 | 3 |
54 | Hamidinia et al. | 2,013 | Colon | SW48 | 48 | Umbelliprenin | 200 | 7.06 | 1.26 | 3 | 100 | 2.29 | 3 |
54 | Hamidinia et al. | 2,013 | Colon | SW48 | 72 | Umbelliprenin | 6.25 | 81.53 | 2.54 | 3 | 100 | 2.29 | 3 |
54 | Hamidinia et al. | 2,013 | Colon | SW48 | 72 | Umbelliprenin | 12.5 | 75.73 | 1.81 | 3 | 100 | 2.29 | 3 |
54 | Hamidinia et al. | 2,013 | Colon | SW48 | 72 | Umbelliprenin | 25 | 69.93 | 2.17 | 3 | 100 | 2.29 | 3 |
54 | Hamidinia et al. | 2,013 | Colon | SW48 | 72 | Umbelliprenin | 50 | 53.99 | 2.9 | 3 | 100 | 2.29 | 3 |
54 | Hamidinia et al. | 2,013 | Colon | SW48 | 72 | Umbelliprenin | 100 | 36.96 | 2.9 | 3 | 100 | 2.29 | 3 |
54 | Hamidinia et al. | 2,013 | Colon | SW48 | 72 | Umbelliprenin | 200 | 4.35 | 1.45 | 3 | 100 | 2.29 | 3 |
55 | Ziai et al. | 2,012 | Leukemia | Jurkat T | 16 | Umbelliprenin | 10 | 92.47 | 1.94 | 3 | 100 | 2.29 | 3 |
55 | Ziai et al. | 2,012 | Leukemia | Jurkat T | 16 | Umbelliprenin | 25 | 86.15 | 3.65 | 3 | 100 | 2.29 | 3 |
55 | Ziai et al. | 2,012 | Leukemia | Jurkat T | 16 | Umbelliprenin | 50 | 63.06 | 2.92 | 3 | 100 | 2.29 | 3 |
55 | Ziai et al. | 2,012 | Leukemia | Jurkat T | 16 | Umbelliprenin | 100 | 39.73 | 2.43 | 3 | 100 | 2.29 | 3 |
55 | Ziai et al. | 2,012 | Leukemia | Jurkat T | 48 | Umbelliprenin | 10 | 69.18 | 2.74 | 3 | 100 | 2.29 | 3 |
55 | Ziai et al. | 2,012 | Leukemia | Jurkat T | 48 | Umbelliprenin | 25 | 50.35 | 3.43 | 3 | 100 | 2.29 | 3 |
55 | Ziai et al. | 2,012 | Leukemia | Jurkat T | 48 | Umbelliprenin | 50 | 25.69 | 3.08 | 3 | 100 | 2.29 | 3 |
55 | Ziai et al. | 2,012 | Leukemia | Jurkat T | 48 | Umbelliprenin | 100 | 13.7 | 3.42 | 3 | 100 | 2.29 | 3 |
56 | Barthomeuf et al. | 2,008 | Colon | DLD1 | 48 | Umbelliprenin | 27.3 | 70.98 | 4.02 | 3 | 100 | 2.29 | 3 |
56 | Barthomeuf et al. | 2,008 | Breast | MCF-7 | 48 | Umbelliprenin | 27.3 | 62.67 | 3.68 | 3 | 100 | 2.29 | 3 |
56 | Barthomeuf et al. | 2,008 | Ovarian | PA1 | 48 | Umbelliprenin | 27.3 | 55.04 | 3.67 | 3 | 100 | 2.29 | 3 |
56 | Barthomeuf et al. | 2,008 | Melanoma | M4Beu | 48 | Umbelliprenin | 27.3 | 3.66 | 1.84 | 3 | 100 | 2.29 | 3 |
56 | Barthomeuf et al. | 2,008 | Prostate | PC3 | 48 | Umbelliprenin | 27.3 | 38.07 | 3.21 | 3 | 100 | 2.29 | 3 |
56 | Barthomeuf et al. | 2,008 | Lung | A549 | 48 | Umbelliprenin | 27.3 | 41.01 | 3.22 | 3 | 100 | 2.29 | 3 |
57 | Kamalkazemi et al. | 2,023 | Colon | HT-29 | 24 | Umbelliprenin | 20 | 77.04 | 2.46 | 3 | 100 | 2.29 | 3 |
57 | Kamalkazemi et al. | 2,023 | Colon | HT-29 | 24 | Umbelliprenin | 40 | 65.3 | 2.45 | 3 | 100 | 2.29 | 3 |
57 | Kamalkazemi et al. | 2,023 | Colon | HT-29 | 24 | Umbelliprenin | 60 | 54.09 | 1.1 | 3 | 100 | 2.29 | 3 |
57 | Kamalkazemi et al. | 2,023 | Colon | HT-29 | 24 | Umbelliprenin | 80 | 42.89 | 2.19 | 3 | 100 | 2.29 | 3 |
57 | Kamalkazemi et al. | 2,023 | Colon | HT-29 | 24 | Umbelliprenin | 100 | 34.15 | 1.09 | 3 | 100 | 2.29 | 3 |
57 | Kamalkazemi et al. | 2,023 | Colon | HT-29 | 24 | Umbelliprenin | 120 | 26.77 | 1.37 | 3 | 100 | 2.29 | 3 |
57 | Kamalkazemi et al. | 2,023 | Colon | HT-29 | 24 | Umbelliprenin | 140 | 19.39 | 2.19 | 3 | 100 | 2.29 | 3 |
57 | Kamalkazemi et al. | 2,023 | Colon | HT-29 | 48 | Umbelliprenin | 20 | 67.87 | 1.33 | 3 | 100 | 2.29 | 3 |
57 | Kamalkazemi et al. | 2,023 | Colon | HT-29 | 48 | Umbelliprenin | 40 | 47.15 | 1.55 | 3 | 100 | 2.29 | 3 |
57 | Kamalkazemi et al. | 2,023 | Colon | HT-29 | 48 | Umbelliprenin | 60 | 38.08 | 0.8 | 3 | 100 | 2.29 | 3 |
57 | Kamalkazemi et al. | 2,023 | Colon | HT-29 | 48 | Umbelliprenin | 80 | 36.01 | 1.03 | 3 | 100 | 2.29 | 3 |
57 | Kamalkazemi et al. | 2,023 | Colon | HT-29 | 48 | Umbelliprenin | 100 | 31.86 | 1.55 | 3 | 100 | 2.29 | 3 |
57 | Kamalkazemi et al. | 2,023 | Colon | HT-29 | 48 | Umbelliprenin | 120 | 21.5 | 1.81 | 3 | 100 | 2.29 | 3 |
57 | Kamalkazemi et al. | 2,023 | Colon | HT-29 | 48 | Umbelliprenin | 140 | 14.24 | 1.56 | 3 | 100 | 2.29 | 3 |
58 | Zhang et al. | 2,019 | Gastric | AGS | 24 | Umbelliprenin | 3.13 | 83.33 | 5.72 | 3 | 99.5 | 2.49 | 3 |
58 | Zhang et al. | 2,019 | Gastric | AGS | 48 | Umbelliprenin | 3.13 | 72.13 | 1.5 | 3 | 100 | 1 | 3 |
58 | Zhang et al. | 2,019 | Gastric | AGS | 72 | Umbelliprenin | 3.13 | 66.16 | 3.98 | 3 | 99.25 | 2.24 | 3 |
58 | Zhang et al. | 2,019 | Gastric | AGS | 24 | Umbelliprenin | 6.25 | 63.68 | 2.73 | 3 | 99.5 | 2.49 | 3 |
58 | Zhang et al. | 2,019 | Gastric | AGS | 48 | Umbelliprenin | 6.25 | 54.71 | 2.5 | 3 | 100 | 1 | 3 |
58 | Zhang et al. | 2,019 | Gastric | AGS | 72 | Umbelliprenin | 6.25 | 52.83 | 4.04 | 3 | 99.25 | 2.24 | 3 |
58 | Zhang et al. | 2,019 | Gastric | AGS | 24 | Umbelliprenin | 12.5 | 34.82 | 3.73 | 3 | 99.5 | 2.49 | 3 |
58 | Zhang et al. | 2,019 | Gastric | AGS | 48 | Umbelliprenin | 12.5 | 32.58 | 2.74 | 3 | 100 | 1 | 3 |
58 | Zhang et al. | 2,019 | Gastric | AGS | 72 | Umbelliprenin | 12.5 | 30.09 | 5.48 | 3 | 99.25 | 2.24 | 3 |
58 | Zhang et al. | 2,019 | Gastric | AGS | 24 | Umbelliprenin | 25 | 24.37 | 1.99 | 3 | 99.5 | 2.49 | 3 |
58 | Zhang et al. | 2,019 | Gastric | AGS | 48 | Umbelliprenin | 25 | 22.13 | 6.97 | 3 | 100 | 1 | 3 |
58 | Zhang et al. | 2,019 | Gastric | AGS | 72 | Umbelliprenin | 25 | 20.14 | 2.99 | 3 | 99.25 | 2.24 | 3 |
58 | Zhang et al. | 2,019 | Gastric | AGS | 24 | Umbelliprenin | 50 | 14.67 | 2.49 | 3 | 99.5 | 2.49 | 3 |
58 | Zhang et al. | 2,019 | Gastric | AGS | 48 | Umbelliprenin | 50 | 12.68 | 2.24 | 3 | 100 | 1 | 3 |
58 | Zhang et al. | 2,019 | Gastric | AGS | 72 | Umbelliprenin | 50 | 10.19 | 3.98 | 3 | 99.25 | 2.24 | 3 |
58 | Zhang et al. | 2,019 | Gastric | BGC-823 | 24 | Umbelliprenin | 3.13 | 89.61 | 5.55 | 3 | 99.51 | 2.42 | 3 |
58 | Zhang et al. | 2,019 | Gastric | BGC-823 | 48 | Umbelliprenin | 3.13 | 83.81 | 1.69 | 3 | 100 | 1.29 | 3 |
58 | Zhang et al. | 2,019 | Gastric | BGC-823 | 72 | Umbelliprenin | 3.13 | 77.29 | 4.11 | 3 | 99.51 | 2.18 | 3 |
58 | Zhang et al. | 2,019 | Gastric | BGC-823 | 24 | Umbelliprenin | 6.25 | 74.39 | 3.14 | 3 | 99.51 | 2.42 | 3 |
58 | Zhang et al. | 2,019 | Gastric | BGC-823 | 48 | Umbelliprenin | 6.25 | 71.98 | 2.41 | 3 | 100 | 1.29 | 3 |
58 | Zhang et al. | 2,019 | Gastric | BGC-823 | 72 | Umbelliprenin | 6.25 | 63.52 | 3.87 | 3 | 99.51 | 2.18 | 3 |
58 | Zhang et al. | 2,019 | Gastric | BGC-823 | 24 | Umbelliprenin | 12.5 | 67.87 | 3.86 | 3 | 99.51 | 2.42 | 3 |
58 | Zhang et al. | 2,019 | Gastric | BGC-823 | 48 | Umbelliprenin | 12.5 | 60.86 | 2.42 | 3 | 100 | 1.29 | 3 |
58 | Zhang et al. | 2,019 | Gastric | BGC-823 | 72 | Umbelliprenin | 12.5 | 60.86 | 6.28 | 3 | 99.51 | 2.18 | 3 |
58 | Zhang et al. | 2,019 | Gastric | BGC-823 | 24 | Umbelliprenin | 25 | 44.92 | 1.45 | 3 | 99.51 | 2.42 | 3 |
58 | Zhang et al. | 2,019 | Gastric | BGC-823 | 48 | Umbelliprenin | 25 | 42.59 | 6.68 | 3 | 100 | 1.29 | 3 |
58 | Zhang et al. | 2,019 | Gastric | BGC-823 | 72 | Umbelliprenin | 25 | 40.09 | 3.14 | 3 | 99.51 | 2.18 | 3 |
58 | Zhang et al. | 2,019 | Gastric | BGC-823 | 24 | Umbelliprenin | 50 | 24.87 | 2.18 | 3 | 99.51 | 2.42 | 3 |
58 | Zhang et al. | 2,019 | Gastric | BGC-823 | 48 | Umbelliprenin | 50 | 23.07 | 2.77 | 3 | 100 | 1.29 | 3 |
58 | Zhang et al. | 2,019 | Gastric | BGC-823 | 72 | Umbelliprenin | 50 | 15.45 | 3.87 | 3 | 99.51 | 2.18 | 3 |
61 | Gkionis et al. | 2,021 | Breast | MCF-7 | 48 | Umbelliprenin | 98 | 50 | 5.61 | 2 | 100 | 2.29 | 2 |
61 | Gkionis et al. | 2,021 | Breast | MDA-MB231 | 48 | Umbelliprenin | 88 | 50 | 5.61 | 2 | 100 | 2.29 | 2 |
61 | Gkionis et al. | 2,021 | Breast | MDA-MB231 | 48 | Umbelliprenin | 0.1 | 99.68 | 5.61 | 2 | 100 | 2.29 | 2 |
61 | Gkionis et al. | 2,021 | Breast | MDA-MB231 | 48 | Umbelliprenin | 1 | 89.71 | 14.65 | 2 | 100 | 2.29 | 2 |
61 | Gkionis et al. | 2,021 | Breast | MDA-MB231 | 48 | Umbelliprenin | 10 | 101.55 | 4.05 | 2 | 100 | 2.29 | 2 |
61 | Gkionis et al. | 2,021 | Breast | MDA-MB231 | 48 | Umbelliprenin | 50 | 95.01 | 6.54 | 2 | 100 | 2.29 | 2 |
61 | Gkionis et al. | 2,021 | Breast | MDA-MB231 | 48 | Umbelliprenin | 100 | 40.8 | 3.74 | 2 | 100 | 2.29 | 2 |
67 | Zhang et al. | 2,015 | Gastric | AGS | 24 | Umbelliprenin | 13.67 | 50 | 2.28 | 3 | 100 | 1.72 | 3 |
67 | Zhang et al. | 2,015 | Cervical | HeLa | 24 | Umbelliprenin | 75.83 | 50 | 2.28 | 3 | 100 | 1.72 | 3 |
67 | Zhang et al. | 2,015 | Lung | A549 | 24 | Umbelliprenin | 121.53 | 50 | 2.28 | 3 | 100 | 1.72 | 3 |
67 | Zhang et al. | 2,015 | Prostate | PC3 | 24 | Umbelliprenin | 88.27 | 50 | 2.28 | 3 | 100 | 1.72 | 3 |
67 | Zhang et al. | 2,015 | Gastric | AGS | 24 | Umbelliprenin | 6.25 | 87.72 | 1.43 | 3 | 97.72 | 1.72 | 3 |
67 | Zhang et al. | 2,015 | Gastric | AGS | 24 | Umbelliprenin | 12.5 | 80.86 | 2.28 | 3 | 97.72 | 1.72 | 3 |
67 | Zhang et al. | 2,015 | Gastric | AGS | 24 | Umbelliprenin | 25 | 71.43 | 2.57 | 3 | 97.72 | 1.72 | 3 |
67 | Zhang et al. | 2,015 | Gastric | AGS | 24 | Umbelliprenin | 50 | 48 | 7.14 | 3 | 97.72 | 1.72 | 3 |
67 | Zhang et al. | 2,015 | Gastric | AGS | 24 | Umbelliprenin | 100 | 20 | 2 | 3 | 97.72 | 1.72 | 3 |
6 | Movaffagh et al. | 2,021 | Gastric | MKN-45 | 24 | Auraptene | 16.7 | 93.61 | 6.39 | 3 | 85.81 | 2.13 | 3 |
6 | Movaffagh et al. | 2,021 | Gastric | MKN-45 | 24 | Auraptene | 33.4 | 85.81 | 2.13 | 3 | 85.81 | 2.13 | 3 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.